Neuren Pharmaceuticals LimitedASX: NEU

Zita Peach to succeed Patrick Davies as Board Chair

· Issued by Neuren Pharmaceuticals Limited via ASX

Filed with ASX · · 3 pages · English

Summary by 6ix AI

Neuren Pharmaceuticals has appointed Zita Peach as the new Chair of the Board, succeeding Patrick Davies. The announcement highlights the company's commitment to growth and innovation in developing treatments for neurodevelopmental disorders. Zita expressed her enthusiasm for guiding Neuren through its next phase of growth and advancing its pipeline.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Neuren (NEU) – ASX Announcement 12 November 2026 Neuren appoints Zita Peach to succeed Patrick Davies as Board Chair Melbourne, Australia: Neuren Pharmaceuticals (ASX: NEU) today announced that Ms Zita Peach has been appointed Chair of the Board following a carefully considered succession...

Neuren Pharmaceuticals Limited on 6ix

Story so far

Earlier from Neuren Pharmaceuticals

Later from Neuren Pharmaceuticals

All Neuren Pharmaceuticals news releases